Company registration number SC164568 (Scotland)
CHIPFUSE LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
CHIPFUSE LIMITED
COMPANY INFORMATION
Directors
Mr M P Kilmurray
Mrs M Kilmurray
Mr J D Beaton
Mrs V A Beaton
Mr Duncan Beaton
Miss Kate Beaton
Miss Katie Kilmurray
Miss Kim Kilmurray
Company number
SC164568
Registered office
6th Floor
Gordon Chambers
90 Mitchell Street
Glasgow
Lanarkshire
United Kingdom
G1 3NQ
Auditor
bk plus Audit Limited
6th Floor
Gordon Chambers
90 Mitchell Street
Glasgow
Scotland
G1 3NQ
CHIPFUSE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
CHIPFUSE LIMITED
BALANCE SHEET
AS AT 31 AUGUST 2025
31 August 2025
- 1 -
31 August 2025
2024
Notes
£
£
£
£
Fixed assets
Investments
4
1,291,798
1,291,798
Capital and reserves
Called up share capital
14,015
14,015
Capital redemption reserve
10,360
10,360
Other reserves
1,171,801
1,171,801
Profit and loss reserves
95,622
95,622
Total equity
1,291,798
1,291,798

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 28 May 2026 and are signed on its behalf by:
Mr M P Kilmurray
Director
Company registration number SC164568 (Scotland)
CHIPFUSE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
1
Accounting policies
Company information

Chipfuse Limited is a private company limited by shares incorporated in Scotland. The registered office is 6th Floor, Gordon Chambers, 90 Mitchell Street, Glasgow, Lanarkshire, United Kingdom, G1 3NQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

 

Chipfuse Limited is a wholly owned subsidiary of Third Life Care Limited and the results of Chipfuse Limited are included in the consolidated financial statements of Third Life Care Limited which are available from Companies House.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.2
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

CHIPFUSE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 3 -
1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CHIPFUSE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 4 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
1,291,798
1,291,798
5
Subsidiaries

Details of the company's subsidiaries at 31 August 2025 are as follows:

Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
Craig-En-Goyne Care Company Limited
6th Floor, Gordon Chambers, 90 Mitchell Street, Glasgow G1 3NQ
Residential care provider
Ordinary
100.00
6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Andrew McAulay FCCA
Statutory Auditor:
bk plus Audit Limited
Date of audit report:
29 May 2026
2025-08-312024-09-01falsefalsefalse29 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr M P KilmurrayMrs M KilmurrayMr J D BeatonMrs V A BeatonMr Duncan BeatonMiss Kate BeatonMiss Katie KilmurrayMiss Kim KilmurraySC1645682024-09-012025-08-31SC164568bus:Director12024-09-012025-08-31SC164568bus:Director22024-09-012025-08-31SC164568bus:Director32024-09-012025-08-31SC164568bus:Director42024-09-012025-08-31SC164568bus:Director52024-09-012025-08-31SC164568bus:Director62024-09-012025-08-31SC164568bus:Director72024-09-012025-08-31SC164568bus:Director82024-09-012025-08-31SC164568bus:RegisteredOffice2024-09-012025-08-31SC1645682025-08-31SC1645682024-08-31SC164568core:ShareCapital2025-08-31SC164568core:ShareCapital2024-08-31SC164568core:CapitalRedemptionReserve2025-08-31SC164568core:CapitalRedemptionReserve2024-08-31SC164568core:OtherMiscellaneousReserve2025-08-31SC164568core:OtherMiscellaneousReserve2024-08-31SC164568core:RetainedEarningsAccumulatedLosses2025-08-31SC164568core:RetainedEarningsAccumulatedLosses2024-08-31SC1645682023-09-012024-08-31SC164568core:Subsidiary12024-09-012025-08-31SC164568core:Subsidiary112024-09-012025-08-31SC164568bus:PrivateLimitedCompanyLtd2024-09-012025-08-31SC164568bus:FRS1022024-09-012025-08-31SC164568bus:Audited2024-09-012025-08-31SC164568bus:SmallCompaniesRegimeForAccounts2024-09-012025-08-31SC164568bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP